Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
16,607
-6,675
-29% -$771K 0.24% 49
2025
Q4
$2.45M Buy
23,282
+433
+2% +$40.6K 0.31% 41
2025
Q3
$1.92M Buy
22,849
+1,218
+6% +$100K 0.25% 42
2025
Q2
$1.71M Buy
21,631
+1,970
+10% +$157K 0.25% 40
2025
Q1
$1.76M Buy
19,661
+1,026
+6% +$95.8K 0.32% 35
2024
Q4
$1.85M Buy
18,635
+6,479
+53% +$668K 0.33% 37
2024
Q3
$1.38M Sell
12,156
-638
-5% -$75.8K 0.26% 46
2024
Q2
$1.58M Buy
12,794
+208
+2% +$26.8K 0.33% 36
2024
Q1
$1.66M Buy
12,586
+1,725
+16% +$213K 0.36% 33
2023
Q4
$1.18M Buy
10,861
+7,400
+214% +$768K 0.32% 31
2023
Q3
$356K Sell
3,461
-3,435
-50% -$370K 0.1% 86
2023
Q2
$796K Sell
6,896
-881
-11% -$100K 0.26% 46
2023
Q1
$827K Buy
7,777
+241
+3% +$26K 0.25% 40
2022
Q4
$836K Buy
7,536
+525
+7% +$53.7K 0.24% 45
2022
Q3
$604K Buy
7,011
+75
+1% +$6.7K 0.18% 53
2022
Q2
$632K Buy
6,936
+1,695
+32% +$150K 0.18% 60
2022
Q1
$430K Sell
5,241
-427
-8% -$33.7K 0.11% 87
2021
Q4
$436K Sell
5,668
-436
-7% -$34.7K 0.13% 87
2021
Q3
$458K Buy
6,104
+119
+2% +$9.05K 0.16% 75
2021
Q2
$465K Sell
5,985
-425
-7% -$31.6K 0.16% 75
2021
Q1
$471K Sell
6,410
-164
-2% -$12.1K 0.19% 67
2020
Q4
$513K Buy
+6,574
New +$503K 0.22% 57

Other funds holding MRK

MJP Associates's MRK Position: Q1 2026 in Review

MJP Associates reduced its Merck (MRK) stake by 29% in Q1 2026, selling an estimated $771K and leaving 16,607 shares worth $2M. The position accounts for 0.24% of the portfolio, ranked #49.

MJP Associates first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.45M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • MJP Associates held 16,607 shares of Merck worth $2M as of Q1 2026.
  • MJP Associates sold 6,675 Merck shares in Q1 2026, an estimated $771K.
  • Merck made up 0.24% of MJP Associates's portfolio in Q1 2026, its #49 holding.
  • MJP Associates first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • MJP Associates's Merck position peaked at $2.45M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.